Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X receptor antagonist
RETTINGER, J, BRAUN, K, HOCHMANN, H, KASSACK, M, ULLMANN, H, NICKEL, P, SCHMALZING, G, LAMBRECHT, G
Published in Neuropharmacology (01.03.2005)
Published in Neuropharmacology (01.03.2005)
Get full text
Journal Article
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor
Rettinger, J, Schmalzing, G, Damer, S, Müller, G, Nickel, P, Lambrecht, G
Published in Neuropharmacology (23.08.2000)
Published in Neuropharmacology (23.08.2000)
Get full text
Journal Article
Roles of Individual N-Glycans for ATP Potency and Expression of the Rat P2X1 Receptor
Rettinger, Jürgen, Aschrafi, Armaz, Schmalzing, Günther
Published in The Journal of biological chemistry (27.10.2000)
Published in The Journal of biological chemistry (27.10.2000)
Get full text
Journal Article
Novel ligands for P2 receptor subtypes in innervated tissues
Lambrecht, G, Damer, S, Niebel, B, Czeche, S, Nickel, P, Rettinger, J, Schmalzing, G, Mutschler, E
Published in Progress in brain research (1999)
Published in Progress in brain research (1999)
Get full text
Journal Article
Evolving view of quaternary structures of ligand-gated ion channels
Nicke, A, Rettinger, J, Büttner, C, Eichele, A, Lambrecht, G, Schmalzing, G
Published in Progress in brain research (1999)
Published in Progress in brain research (1999)
Get full text
Journal Article
The suramin analog 4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis (carbonylimino)))tetra-kis-benzenesulfonic acid (NF110) potently blocks P2X3 receptors: subtype selectivity is determined by location of sulfonic acid groups
Hausmann, Ralf, Rettinger, Jürgen, Gerevich, Zoltan, Meis, Sabine, Kassack, Matthias U, Illes, Peter, Lambrecht, Günter, Schmalzing, Günther
Published in Molecular pharmacology (01.06.2006)
Published in Molecular pharmacology (01.06.2006)
Get full text
Journal Article
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X1 receptor
RETTINGER, J, SCHMALZING, G, DAMER, S, MÜLLER, G, NICKEL, P, LAMBRECHT, G
Published in Neuropharmacology (01.10.2000)
Published in Neuropharmacology (01.10.2000)
Get full text
Journal Article
NF449: a subnanomolar potency antagonist at recombinant rat P2X1 receptors
Braun, K, Rettinger, J, Ganso, M, Kassack, M, Hildebrandt, C, Ullmann, H, Nickel, P, Schmalzing, G, Lambrecht, G
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.09.2001)
Published in Naunyn-Schmiedeberg's archives of pharmacology (01.09.2001)
Get full text
Journal Article
Roles of Individual N-Glycans for ATP Potency and Expression of the Rat P2X sub(1) Receptor
Rettinger, J, Aschrafi, A, Schmalzing, G
Published in The Journal of biological chemistry (27.10.2000)
Published in The Journal of biological chemistry (27.10.2000)
Get full text
Journal Article
Profiling at recombinant homomeric and heteromeric rat P2X receptors identifies the suramin analogue NF449 as a highly potent P2X sub(1) receptor antagonist
Rettinger, J, Braun, K, Hochmann, H, Kassack, MU, Ullmann, H, Nickel, P, Schmalzing, G, Lambrecht, G
Published in Neuropharmacology (01.03.2005)
Published in Neuropharmacology (01.03.2005)
Get full text
Journal Article
NF279: a novel potent and selective antagonist of P2X receptor-mediated responses
Damer, Susanne, Niebel, Beate, Czeche, Sittah, Nickel, Peter, Ardanuy, Ursula, Schmalzing, Günther, Rettinger, Jürgen, Mutschler, Ernst, Lambrecht, Günter
Published in European journal of pharmacology (29.05.1998)
Published in European journal of pharmacology (29.05.1998)
Get full text
Journal Article
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptors
Lambrecht, G, Rettinger, J, Bäumert, H G, Czeche, S, Damer, S, Ganso, M, Hildebrandt, C, Niebel, B, Spatz-Kümbel, G, Schmalzing, G, Mutschler, E
Published in European journal of pharmacology (17.01.2000)
Published in European journal of pharmacology (17.01.2000)
Get full text
Journal Article
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X1 receptors
LAMBRECHT, G, RETTINGER, J, MUTSCHLER, E, BÄUMERT, H. G, CZECHE, S, DAMER, S, GANSO, M, HILDEBRANDT, C, NIEBEL, B, SPATZ-KÜMBEL, G, SCHMALZING, G
Published in European journal of pharmacology (01.01.2000)
Published in European journal of pharmacology (01.01.2000)
Get full text
Journal Article
The suramin analogue NF279 is a novel and potent antagonist selective for the P2X sub(1) receptor
Rettinger, J, Schmalzing, G, Damer, S, Mueller, G, Nickel, P, Lambrecht, G
Published in Neuropharmacology (01.08.2000)
Get full text
Published in Neuropharmacology (01.08.2000)
Journal Article